Rolf Lood

Rolf has a background in Biomedicine and received his Ph.D. in Experimental Infection Medicine from Lund University, Sweden. Rolf started his career in 2007 working on the skin bacterium Propionibacterium acnes and bacteriophages infecting this bacterium. This research path has continuously been a major part of the research conducted in the Lood lab. Rolf is focusing his research within the field of Experimental Infection Medicine, with an emphasis on a) understanding the beneficial (molecular) role of the skin microbiota, b) elucidating molecular mechanisms behind the spread of antibiotic resistance through bacteriophages, and c) investigating experimental means to combat infections. During the last years, a specific focus has been on the P. acnes secreted benevolence factor RoxP identified and characterized by the lab–a potent antioxidant able to protect human skin from oxidative damage.

Besides his academic position, Rolf is the CSO of the biotechnology company Genovis AB, developing enzymes for the study of immunoglobulins.